Women’s health is widening its scope to midlife

For most of modern healthcare, menopause has been treated as something to simply endure. The symptoms — hot flashes, brain fog, sleep disruption — are familiar and recognized by many. Accessible treatment options and support? Far less so.

That’s starting to change. More companies are paying attention to what midlife actually looks like in real life and building tools that offer clearer guidance. For consumers, it means fewer dead ends, faster answers, and care that’s easier to access — a noticeable shift from the trial-and-error approach many women have had to rely on.

What’s changing

Companies are entering menopause care with different approaches: some are making specialist care and prescriptions easier to access, while others are creating tracking tools to help people understand what’s happening in their bodies.

• Hers launched menopause and perimenopause personalized treatment plans, expanding beyond its existing weight loss and sexual health offerings.
• Midi Health is building an AI search engine for women’s health, tackling the problem of outdated or inaccurate information about menopause online.

• Natural Cycles, known for its FDA-cleared birth control app, added perimenopause tracking to help women understand hormonal shifts across life stages.
• Alloy focuses on evidence-based hormone therapy and education, cutting through the confusion that’s kept many women from pursuing treatment.

Across all of these approaches, the theme is the same: reducing friction. Women are gaining better access to hormone therapy, lab work, and symptom tracking through platforms built around convenience and clarity.

Why this matters now

Most women hit perimenopause without knowing what’s happening. Doctors often aren’t trained to recognize the full scope, either, so symptoms get treated as separate issues instead of one transition. 

What’s shifting is that menopause is finally being treated like a health stage that deserves its own treatment. But wellness has a pattern of building quickly for underserved categories, then moving on when growth slows. The real question isn’t whether these platforms are useful now — it’s whether they’ll still be here in five or ten years and make a long-term impact.